Sagimet Biosciences (SGMT) Share-based Compensation: 2022-2024
Historic Share-based Compensation for Sagimet Biosciences (SGMT) over the last 3 years, with Dec 2024 value amounting to $5.3 million.
- Sagimet Biosciences' Share-based Compensation fell 16.66% to $1.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.1 million, marking a year-over-year change of. This contributed to the annual value of $5.3 million for FY2024, which is 5.97% up from last year.
- Sagimet Biosciences' Share-based Compensation amounted to $5.3 million in FY2024, which was up 5.97% from $5.0 million recorded in FY2023.
- In the past 5 years, Sagimet Biosciences' Share-based Compensation ranged from a high of $5.3 million in FY2024 and a low of $1.9 million during FY2022.
- For the 3-year period, Sagimet Biosciences' Share-based Compensation averaged around $4.1 million, with its median value being $5.0 million (2023).
- Data for Sagimet Biosciences' Share-based Compensation shows a peak YoY spiked of 165.43% (in 2023) over the last 5 years.
- Over the past 3 years, Sagimet Biosciences' Share-based Compensation (Yearly) stood at $1.9 million in 2022, then soared by 165.43% to $5.0 million in 2023, then climbed by 5.97% to $5.3 million in 2024.